QUOTED. Monika Paule.

Caszyme CEO and 2022 In Vivo Rising Leader Monika Paule is on a mission to expand the CRISPR toolbox of available proteins to enhance diagnostic tools, therapeutics and even agricultural practices.

Quoted Column

More from Leadership

More from Medtech Insight